1
Hermann Katinger, Karola Vorauer Uhl, Andreas Wagner, Guenter Kreismayr: Method and device for producing lipid vesicles. Polymun Scientific Immunobilogische Forschung, Rothwell Figg Ernst & Manbeck PC, January 18, 2005: US06843942 (29 worldwide citation)

The invention relates to a device for producing lipid vesicles, which is equipped with a line (1) for transporting a polar liquid phase, with a line (2) for transporting an organic liquid phase containing lipids, with a collecting receptacle (7) for accommodating produced lipid vesicles, and with me ...


2
Hermann Katinger, Florian Ruker, Gottfried Himmler, Thomas Muster, Alexandra Trkola, Martin Purtscher, Georg Maiwald, Franz Steindl: Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates. Hermann Katinger, Birch Stewart Kolasch & Birch, February 2, 1999: US05866694 (21 worldwide citation)

This invention concerns peptides binding to antibodies which show neutralizing activity against different strains and clinical isolates of HIV-1 and which inhibit the fusion of cells infected with HIV-1. These peptides are combined with an adjuvant, as recombinant fusion proteins, chemically coupled ...


3
Hermann Katinger, Karola Vorauer Uhl, Claus Riedl: Liposomal recombinant human superoxide-dismutase for the treatment of peyronie's disease. Polymun Scientific Immunbiogische Forschung, Oliff & Berridge, November 6, 2001: US06312720 (15 worldwide citation)

Superoxide dismutase (SOD), preferably rhSOD, is used in liposomes, optionally mixed with hyaluronic acid and/or at least one physiologically acceptable carrier, and other optional additives, to prepare a pharmaceutical composition useful against increased concentrations of superoxide radicals and/o ...


4
Hermann Katinger, Andre Egorov, Boris Ferko, Julia Romanova, Dietmar Katinger: Live attenuated influenza vaccine. Polymun Scientific Immunbiologische Forschung, Ostrolenk Faber Gerb & Soffen, February 24, 2009: US07494659 (12 worldwide citation)

The invention relates to a simple and efficient process for isolating viruses from various sources and for producing live attenuated influenza vaccines in a serum-free Vero cell culture under conditions where alterations in the surface antigens of the virus due to adpative selection are minimized or ...


5
Hermann Katinger, Winfried Scheirer: Method of cultivating cells of animal and human tissues. Chemap, Michael J Striker, March 31, 1981: US04259449 (10 worldwide citation)

A method of cultivating cells of animal and human tissues includes the steps of introducing the cells into a nutrient solution in which they tend to settle, and maintaining the cells in the solution in a suspended state so as to prevent their settling by introducing an oxygen-containing gas into the ...


6
Hermann Katinger, Winfried Scheirer: Method of and an arrangement for cultivating cells of animal and human tissues. Chemap, Michael J Striker, January 19, 1982: US04311798 (9 worldwide citation)

A method of cultivating cells of animal and human tissues includes the steps of introducing the cells into a nutrient solution in which they tend to settle, and maintaining the cells in the solution in a suspended state so as to prevent their settling by introducing an oxygen-containing gas to the s ...


7
Hermann Katinger, Winfried Scheirer: Device for cultivating cells of animal and human tissues. Chemap, Michael J Striker, November 6, 1979: US04173516 (9 worldwide citation)

A method of cultivating cells of animal and human tissues includes the steps of introducing the cells into a nutrient solution in which they tend to settle, and maintaining the cells in the solution in a suspended state so as to prevent their settling by introducing an oxygen-containing gas into the ...


8
Hermann Katinger, Andrea Buchacher, Wolfgang Ernst, Claudia Ballaun, Martin Purtscher, Alexandra Trkola, Renate Predl, Christine Schmatz, Annelies Klima, Franz Steindl, Thomas Muster: HIV-vaccines. Polynum Scientific Immunbiologische Forschung, Birch Stewart Kolasch & Birch, June 15, 1999: US05911989 (9 worldwide citation)

Disclosed are antibodies which can be used for the manufacture of vaccines for active and/or passive immunization of persons in need of such treatment. The invention also provides for human monoclonal antibodies that are functionally equivalent to the above-mentioned antibodies produced by any one o ...


9
Hermann Katinger, Alois Jungbauer, Franz Steindl, Andrea Buchacher: Human monoclonal anti-HIV-I-antibodies. Hermann Katinger, Bierman Muserlian and Lucas, November 3, 1998: US05831034 (9 worldwide citation)

Novel human monoclonal anti-HIV-I antibodies and immunochemicals made from the antibodies and method of treating or preventing HIV-I infections.


10
Hermann Katinger, Florian Ruker, Gottfried Himmler, Thomas Muster, Alexandra Trkola, Martin Purtscher, Georg Maiwald, Franz Steindl: Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates. Herman Katinger, May 26, 1998: US05756674 (8 worldwide citation)

The present invention relates to fusion peptides wherein at least one peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 25 is bound to an adjuvant being a protein molecule by fusion of the respective nucleotide sequences and subsequent ...